To view PDF documents
External links included in this website should not be construed as an official endorsement of the views contained therein.
|
 |
Notice of Application - 2012
- ISP
Freetown Fine Chemicals (December 27, 2012)
- Hospira (December 21, 2012)
- Mylan
Pharmaceuticals, Inc. (December 5, 2012)
- Fisher
Clinical Services, Inc. (December 5, 2012)
- Johnson
Matthey, Inc. (November 27, 2012)
- Watson
Pharma, Inc. (November 13, 2012)
- Fisher
Clinical Services, Inc. (November 9, 2012)
- Noramco, Inc. (October 18, 2012)
- Fisher
Clinical Services, Inc. (October 2, 2012)
- Lipomed (August 20, 2012)
- Clinical Supplies Management, Inc. (August 20, 2012)
- SA INTL
GMBH C/O., Sigma Aldrich Co., LLC (August 20, 2012)
- Cerilliant Corporation (August 20, 2012)
- R & D
Systems, Inc. (August 20, 2012)
- Cody
Laboratories, Inc. (July 26, 2012)
- Akorn,
Inc. (July 26, 2012)
- Boehringer Ingelheim Chemicals (July 26, 2012)
- ISP
Freetown Fine Chemicals (July 11, 2012)
- United
States Pharmacopeial Convention (July 11, 2012)
- Chattem
Chemicals Inc. (July 6, 2012)
- Myoderm (July 5, 2012)
- Cambrex
Charles City, Inc. (June 26, 2012)
- Importer of Controlled Substances Notice of Application (Correction) (June 14, 2012)
- Arizona Department of Corrections (June 12, 2012)
- Research Triangle Institute (June 8, 2012)
- Alltech
Associates, Inc. (May 25, 2012)
- Noramco, Inc. (May 25, 2012)
- Stepan
Company (May 21, 2012)
- Penick Corporation (April 26, 2012)
- Clinical Supplies Management, Inc. (April 26, 2012)
- Catalent Pharma Solutions, Inc. (April 26, 2012)
- Rhodes Technologies (April 26, 2012)
- Almac Clinical Services, Inc., (ACSI) (April 26, 2012)
- Meda Pharmaceuticals Inc. (April 12, 2012)
- Lipomed, Inc. (April 12, 2012)
- Meridian
Medical Technologies (April 2, 2012)
- Cerilliant Corporation (March 20, 2012)
- Mylan
Technologies Inc. (March 20, 2012)
- Capricorn Pharma Inc. (March 20, 2012)
- Mylan Pharmaceuticals, Inc. (March 1, 2012)
- Formulation Technologies LLC. (February 6, 2012)
- Mallinckrodt LLC. (January 31, 2012)
- Cerilliant Corporation (January 17, 2012)
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
|
